Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital
NCT04380792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2497
Last updated 2020-12-14
Summary
The main objectives are:
* To establish the prevalence of deep venous thrombosis through ultrasonography in Patients infected with COVID-19 admitted to hospital.
* To identify patients with higher risk of deep venous thrombosis.
Conditions
Sponsors & Collaborators
-
Manuel Monreal
lead OTHER
Principal Investigators
-
Manuel Monreal · Germans Trias i Pujol Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-13
- Primary Completion
- 2020-10-13
- Completion
- 2020-10-13
Countries
- Spain
Study Locations
More Related Trials
-
Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic
NCT04400877 ·Status: COMPLETED
-
Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19
NCT04377997 ·Status: UNKNOWN ·Phase: PHASE2
-
COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications
NCT04535128 ·Status: COMPLETED
-
Coronavirus Disease (COvid-)19 REgistry on THROMBOSIS Complications
NCT04780295 ·Status: COMPLETED
-
Deep Venous Thrombosis and Long Term Complications
NCT05789108 ·Status: RECRUITING ·Phase: NA
-
Impact of an Intensified Thromboprofylaxis Protocol in COVID-19
NCT04394000 ·Status: COMPLETED
-
Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto
NCT04393805 ·Status: COMPLETED
-
Diagnostic Approach of Deep Vein Thrombosis in Primary Care
NCT01595763 ·Status: UNKNOWN
-
Epidemiology of Thromboembolism Disease: A Cohort Study
NCT00670540 ·Status: COMPLETED
-
Comparative Study Between Thrombosis Prophylaxis Protocols
NCT00713973 ·Status: COMPLETED
-
Description of a Cohort of Covid-19 Patients With a Circulating Anticoagulant
NCT05075928 ·Status: UNKNOWN
-
Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19
NCT04373707 ·Status: COMPLETED ·Phase: PHASE4
-
COVID-19 and Venous Thromboembolism Risk
NCT04569344 ·Status: COMPLETED
-
Venous Thromboembolism During COVID-19 Pandemic: Evaluation of the Association With the Vaccine and COVID-19 Infection
NCT06806800 ·Status: COMPLETED
-
Thrombosis and Covid-19
NCT04366778 ·Status: COMPLETED
-
Venous Thrombosis Virtual Surveillance in COVID-19
NCT04865913 ·Status: COMPLETED
-
Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection
NCT04508439 ·Status: UNKNOWN ·Phase: NA
-
Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19
NCT04367662 ·Status: COMPLETED ·Phase: NA
-
ANTIcoagulation in Severe COVID-19 Patients
NCT04808882 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of the Coagulopathy Developed by COVID-19 Infected Patients
NCT04356950 ·Status: COMPLETED
-
COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
NCT04787510 ·Status: COMPLETED
-
DVT Burden and the Risk of Post-thrombotic Syndrome
NCT06385353 ·Status: RECRUITING ·Phase: NA
-
Diagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower Limbs
NCT03868956 ·Status: COMPLETED ·Phase: NA
-
Collection of the Thrombo-VaxCov Cohort
NCT04889326 ·Status: WITHDRAWN
-
Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)
NCT04730856 ·Status: COMPLETED ·Phase: NA